Dosering ved sengetid synes at forbedre tolerabiliteten af disse symptomer og kan anbefales i de første uger af behandlingen samt hos patienter, der fortsat oplever disse symptomer (se pkt.
Dosing at bedtime seems to improve the tolerability of these symptoms and can be recommended during the first weeks of therapy and in patients who continue to experience